130 related articles for article (PubMed ID: 33506902)
1. Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.
Mu Y; Liu WJ; Bie LY; Mu XQ; Zhao YQ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):145-153. PubMed ID: 33506902
[TBL] [Abstract][Full Text] [Related]
2. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Xuan YW; Liao M; Zhai WL; Peng LJ; Tang Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8411-8421. PubMed ID: 31646571
[TBL] [Abstract][Full Text] [Related]
4. Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.
Wang X; Huang R; Lu Z; Wang Z; Chen X; Huang D
Cancer Sci; 2022 Mar; 113(3):986-1001. PubMed ID: 35092121
[TBL] [Abstract][Full Text] [Related]
5. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
6. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
Wang M; Liao Q; Zou P
Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
[TBL] [Abstract][Full Text] [Related]
7. LINC00324 exerts tumor-promoting functions in lung adenocarcinoma via targeting miR-615-5p/AKT1 axis.
Pan ZH; Guo XQ; Shan J; Luo SX
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8333-8342. PubMed ID: 30556874
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway.
Tong L; Han WZ; Wang JL; Sun NN; Zhuang M
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4836-4845. PubMed ID: 32432746
[TBL] [Abstract][Full Text] [Related]
9. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
Suo ST; Gong P; Peng XJ; Niu D; Guo YT
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway.
Zhang G; Wu YJ; Yan F
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9480-9488. PubMed ID: 31773700
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.
Miao Y; Liu J
Clin Transl Oncol; 2024 Feb; 26(2):398-413. PubMed ID: 37479901
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circCRIM1 suppresses lung adenocarcinoma cell migration, invasion, EMT, and glycolysis through regulating miR-125b-5p/BTG2 axis.
Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YA; Zhang YJ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3761-3774. PubMed ID: 32329853
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423
[TBL] [Abstract][Full Text] [Related]
17. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
19. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]